Literature DB >> 2674767

The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE).

D Uhlenbrock1, S Sehlen.   

Abstract

The aim of the study was to define reliable criteria for the differentiation of MR imaging between patients with MS and with "vascular" white matter lesions/SAE. We examined 35 patients with proven MS according to the Poser criteria and 35 patients with other white matter lesions and/or SAE. The result is that with MR a differentiation can be achieved provided that T1-weighted spin-echo sequences are included and the different pattern of distribution is considered. MS plaques are predominantly located in the subependymal region, vascular white matter lesions are mainly located in the water-shed of the superficial middle cerebral branches and the deep perforating long medullary vessels in the centrum semiovale. Infratentorial lesions are more often seen in MS. Confluence at the lateral ventricles is frequently accompanied by confluent abnormalities around the third ventricle, Sylvian aqueduct, and fourth ventricle, which is uncommon in SAE. In MS many lesions visible on T2-weighted images have a cellular or intracellular composition that renders them visible also on T1-weighted ones as regions with low signal intensity and more or less distinct boundary. "Vascular" white matter lesions and SAE mainly represent demyelination and can therefore be seen on T2-weighted images, but corresponding low signal intensity lesions on T1-weighted images are uncommon. In some exceptions there are such lesions with low signal representing lacunar infarcts or widened Virchow-Robin-spaces.

Entities:  

Mesh:

Year:  1989        PMID: 2674767     DOI: 10.1007/bf00344344

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  24 in total

1.  Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies.

Authors:  A E George; M J de Leon; A Kalnin; L Rosner; A Goodgold; N Chase
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jul-Aug       Impact factor: 3.825

2.  Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies.

Authors:  A E George; M J de Leon; C I Gentes; J Miller; E London; G N Budzilovich; S Ferris; N Chase
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jul-Aug       Impact factor: 3.825

3.  MRI periventricular lesions in adults.

Authors:  G Gerard; L A Weisberg
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

4.  A histometric study of cerebral and renal arteries in normotensives and chronic hypertensives.

Authors:  T A Cook; P O Yates
Journal:  J Pathol       Date:  1972-10       Impact factor: 7.996

5.  MR imaging of the aging brain: patchy white-matter lesions and dementia.

Authors:  M Brant-Zawadzki; G Fein; C Van Dyke; R Kiernan; L Davenport; J de Groot
Journal:  AJNR Am J Neuroradiol       Date:  1985 Sep-Oct       Impact factor: 3.825

6.  MR imaging in multiple sclerosis: comparison with clinical, CSF, and visual evoked potential findings.

Authors:  D Uhlenbrock; D Seidel; W Gehlen; H K Beyer; J Haan; E Dickmann; T Zeit; E Herbe
Journal:  AJNR Am J Neuroradiol       Date:  1988 Jan-Feb       Impact factor: 3.825

Review 7.  Lacunes.

Authors:  J P Mohr
Journal:  Stroke       Date:  1982 Jan-Feb       Impact factor: 7.914

8.  NMR imaging of experimental brain abscess: comparison with CT.

Authors:  M Brant-Zawadzki; D R Enzmann; R C Placone; P Sheldon; R H Britt; R C Brasch; L A Crooks
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

9.  Proton nuclear magnetic resonance studies on brain edema.

Authors:  S Naruse; Y Horikawa; C Tanaka; K Hirakawa; H Nishikawa; K Yoshizaki
Journal:  J Neurosurg       Date:  1982-06       Impact factor: 5.115

10.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

Authors:  I E Ormerod; D H Miller; W I McDonald; E P du Boulay; P Rudge; B E Kendall; I F Moseley; G Johnson; P S Tofts; A M Halliday
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

View more
  13 in total

Review 1.  Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome.

Authors:  M Rovaris; C Pedroso; M Filippi
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  Segmentation and quantification of black holes in multiple sclerosis.

Authors:  Sushmita Datta; Balasrinivasa Rao Sajja; Renjie He; Jerry S Wolinsky; Rakesh K Gupta; Ponnada A Narayana
Journal:  Neuroimage       Date:  2005-08-26       Impact factor: 6.556

Review 3.  Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Authors:  J H Simon
Journal:  West J Med       Date:  1996-06

4.  Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study.

Authors:  M Rovaris; B Viti; G Ciboddo; S Gerevini; R Capra; G Iannucci; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

5.  Incidental high-intensity foci in white matter on T2-weighted magnetic resonance imaging. Frequency and clinical significance in symptom-free adults.

Authors:  T Horikoshi; S Yagi; A Fukamachi
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?

Authors:  Nina Lummel; Tobias Boeckh-Behrens; Veronika Schoepf; Michael Burke; Hartmut Brückmann; Jennifer Linn
Journal:  Neuroradiology       Date:  2010-06-29       Impact factor: 2.804

7.  Neuroradiological evaluation of demyelinating disease.

Authors:  Jan-Mendelt Tillema; Istvan Pirko
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

8.  Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.

Authors:  Adrienne N Dula; Siddharama Pawate; Richard D Dortch; Robert L Barry; Kristen M George-Durrett; Bailey D Lyttle; Lindsey M Dethrage; John C Gore; Seth A Smith
Journal:  Mult Scler       Date:  2015-07-24       Impact factor: 6.312

9.  Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.

Authors:  Belinda S Y Li; Juleiga Regal; Brian J Soher; Lois J Mannon; Robert I Grossman; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

10.  Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.

Authors:  F Alcindor; R Valderrama; M Canavaggio; H Lee; A Katz; C Montesinos; R E Madrid; R R Merino; P A Pipia
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.